Working with TipRanks
Follow Us
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
Pear Therapeutics (PEAR)
NASDAQ:PEAR
Pear Therapeutics (PEAR) Stock Price & Analysis
0 Followers
PEAR Stock Chart & Stats
Day’s Range$0.03 - $0.042
52-Week Range― - ―
Previous Close$0.05
Volume66.30M
Average Volume (3M)N/A
Market Cap
$4.17M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)N/A
BetaN/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding142,739,169
10 Day Avg. Volume6,351,234
30 Day Avg. Volume3,199,214
Standard Deviation0.25
R-Squared0.01
Alpha-0.10
Financial Highlights & Ratios
Price to Book (P/B)1.05
Price to Sales (P/S)1.59
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-0.40
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$4.50Price Target Upside15310.96% Upside
Rating ConsensusHold
Number of Analyst Covering3
Pear Therapeutics News
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
PEAR FAQ
What was Pear Therapeutics’s price range in the past 12 months?
Currently, no data Available
What is Pear Therapeutics’s market cap?
Currently, no data Available
When is Pear Therapeutics’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Pear Therapeutics’s earnings last quarter?
Currently, no data Available
Is Pear Therapeutics overvalued?
According to Wall Street analysts Pear Therapeutics’s price is currently Undervalued.
Does Pear Therapeutics pay dividends?
Pear Therapeutics does not currently pay dividends.
What is Pear Therapeutics’s EPS estimate?
Pear Therapeutics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Pear Therapeutics have?
Currently, no data Available
What happened to Pear Therapeutics’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Pear Therapeutics?
Among the largest hedge funds holding Pear Therapeutics’s share is Perceptive Advisors LLC. It holds Pear Therapeutics’s shares valued at 1M.
---
Pear Therapeutics Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$4.50 (15310.96% Upside)
$4.50 (15310.96% Upside)
Blogger Sentiment
Bullish
PEAR Sentiment 100%
Sector Average 71%
Sector Average 71%
Insider Transactions
Sold Shares
Worth $2.1M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 1.7%
Last 30 Days ▲ 9.4%
Last 30 Days ▲ 9.4%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Learn more about TipRanks Smart Score
Company Description
Pear Therapeutics
Thimble Point Acquisition Corp is a blank check company. it is formed for the purpose of effectuating a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or other similar business.
---
Top 5 ETFs holding PEAR
Vanguard Total Stock Market ETF
$425.97K
Vanguard Russell 3000 ETF
$936.00
Up to five ETFs with an Outperform Smart Score that hold PEAR. The ETFs are listed according to market value of PEAR within the ETF
Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.
---